Reporter gene imaging: effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes …

KW Morin, EE Knaus, LI Wiebe, H Xia… - Nuclear medicine …, 2000 - journals.lww.com
Perfusion, hypoxia and nucleoside uptake during ganciclovir therapy were determined in a
murine HSV-1 TK-expressing tumour model (KBALB-STK). HSV-1 TK mRNA transcription in …

[PDF][PDF] Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir

SS Gambhir, JR Barrio, L Wu, M Iyer… - Journal of Nuclear …, 1998 - Soc Nuclear Med
We are developing procedures to repeatedly and noninvasively ¡ magethe expression of
transplanted reporter genes in living ani mals and in patients, using PET. We have …

Non-invasive scintigraphic monitoring of gene expression in a HSV-1 thymidine kinase gene therapy model

KW Morin, EE Knaus, LI Wiebe - Nuclear medicine …, 1997 - journals.lww.com
In vivo transduction of the herpes simplex virus type-1 thymidine kinase (HSV-1 TK) gene
and subsequent administration of antiviral drugs such as ganciclovir has emerged as a …

Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and [18F]FHPG

R Hustinx, CY Shiue, A Alavi, D McDonald… - European journal of …, 2001 - Springer
Radiolabelled ganciclovir analogues have shown promise as imaging agents to detect
herpes simplex virus thymidine kinase (HSV tk) expression. This study evaluated the use of …

Assessment of treatment response by autoradiography with 14C-aminocyclopentane carboxylic acid, 67Ga-DTPA, and 18F-FDG in a herpes simplex virus thymidine …

T Miyagawa, T Oku, T Sasajima, R Dasai… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Assessments of herpes simplex virus 1 thymidine kinase (HSV-tk)/ganciclovir (GCV)
treatment response, early in the course of therapy, are important in the evaluation and …

Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation …

HE Wang, HM Yu, RS Liu, M Lin… - Journal of Nuclear …, 2006 - Soc Nuclear Med
The ability to monitor tumor responses during prodrug activation gene therapy and other
anticancer gene therapies is critical for their translation into clinical practice. Previously, we …

[PDF][PDF] Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir

U Haberkorn, A Altmann, I Morr… - Journal of Nuclear …, 1997 - Soc Nuclear Med
Methods: Morris hepatoma cells were transfected with a retroviral vector bearing the HSVtk
gene, and different clones were estab lished by selection with the neomycin analog G418 …

Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography

JG Tjuvajev, N Avril, T Oku, T Sasajima, T Miyagawa… - Cancer research, 1998 - AACR
We report a series of studies that assess the feasibility and sensitivity of imaging of herpes
virus type one thymidine kinase (HSV1-tk) gene transfer and expression with [124I]-5-iodo …

Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET

JC Tseng, PB Zanzonico, B Levin, R Finn… - Journal of Nuclear …, 2006 - Soc Nuclear Med
One type of gene therapy of tumors, gene-directed enzyme-prodrug therapy (GDEPT), holds
considerable promise, although practical considerations limit its clinical applicability. These …

Ganciclovir mediated regression of rat brain tumors expressing the herpes simplex virus thymidine kinase imaged by magnetic resonance

A Maron, T Gustin, I Mottet, R Demeure… - Journal of neuro …, 1995 - Springer
Using a rat C6 brain tumor model, we studied the antitumor effects of Herpes simplex virus
type 1 thymidine kinase (HSV-tk) gene transfer followed by ganciclovir treatment. C6 glioma …